Unverified50% confidenceOpinionExact time
The study's conclusion is currently closer to a signal worth in-depth verification than to a clinical guideline.
1
Sources
50%
Confidence
Medium-term (~90 days)
Relevance
10/24/2026
First Seen
Valid until: 1/22/2027
Sources
Related Entities
Related Claims
UnverifiedIn the absence of long-term follow-up data, any preliminary observation can only be regarded as an exploratory signal rather than an established clinical conclusion.74% similarUnverifiedThe weak cross-platform ranking correlation suggests that methodological robustness and generalizability of conclusions are different things, and further cross-data-source consistency validation is still needed before advancing toward clinical decision-making.73% similarUnverifiedThe 2–6% figure should be treated as a signal warranting deeper investigation rather than a conclusion that can be directly cited.71% similarUnverifiedThe authors position the contribution of this study as methodological robustness under fragmented assessment, rather than providing a clinical drug resistance ranking.69% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1092215API
curl https://kongchang.com/api/v1/knowledge/claims/1092215MCP
get_claim(id=1092215)